Coalition Agreement Presented: Sanity Group Welcomes Planned Evaluation of Cannabis Law and Calls for Scientific Pilot Projects

“It is the right step that the coalition intends to evaluate the Cannabis Act as planned, to assess how the partial legalization has impacted issues such as youth protection, public health, and fighting the illicit market,” says Finn Age Haensel, founder and CEO of Sanity Group. “At the same time, it is crucial to fully implement the law first. That is why we call for the prompt approval of scientific pilot projects for the distribution of recreational cannabis through licensed specialty stores. These will allow us to gain new insights based on solid data and practical experience. Only through a data-driven and scientifically grounded analysis can we implement the right measures to establish a quality-assured and responsible cannabis market while minimizing health risks to the population.” 

Ensuring Medical Care: Cannabis Patients in Focus 
In the field of medical cannabis, Sanity Group calls for continuous improvements in supply security. “The needs of patients must continue to be front and center. We advocate for widespread, low-threshold access to medical cannabis therapy that consistently upholds the highest standards of quality and safety,” explains Haensel. “Medical treatment with cannabis-based medicines should be made as accessible and straightforward as possible for all who need it.” 

With the evaluation of the Cannabis Act, the new government is sending a clear signal for an evidence-based approach to recreational cannabis. Sanity Group is convinced that the introduction of scientific pilot projects will promote the responsible distribution of cannabis and pave the way for a modern drug policy.